1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
  • 1.2.2 Antacids
  • 1.2.3 Pro-kinetic agents
  • 1.2.4 H2 Receptor Blockers
  • 1.2.5 Proton Pump Inhibitors (PPIs)
• 1.3 Market by Application
  • 1.3.1 Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Application: 2020 VS 2026
  • 1.3.2 Heartburn
  • 1.3.3 Acid reflux disorders
• 1.4 Study Objectives
• 1.5 Years Considered

2 Global Growth Trends

• 2.1 Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Perspective (2015-2026)
• 2.2 Global Gastroesophageal Reflux Disease (GERD) Therapeutics Growth Trends by Regions
  • 2.2.1 Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Gastroesophageal Reflux Disease (GERD) Therapeutics Historic Market Share by Regions (2015-2020)
  • 2.2.3 Gastroesophageal Reflux Disease (GERD) Therapeutics Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Gastroesophageal Reflux Disease (GERD) Therapeutics Players by Market Size
  • 3.1.1 Global Top Gastroesophageal Reflux Disease (GERD) Therapeutics Players by Revenue (2015-2020)
  • 3.1.2 Global Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue Market Share by Players (2015-2020)
• 3.2 Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.3 Players Covered: Ranking by Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue
• 3.4 Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Concentration Ratio
  • 3.4.1 Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue in 2019
• 3.5 Key Players Gastroesophageal Reflux Disease (GERD) Therapeutics Area Served
• 3.6 Key Players Gastroesophageal Reflux Disease (GERD) Therapeutics Product Solution and Service
• 3.7 Date of Enter into Gastroesophageal Reflux Disease (GERD) Therapeutics Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Gastroesophageal Reflux Disease (GERD) Therapeutics Breakdown Data by Type (2015-2026)

• 4.1 Global Gastroesophageal Reflux Disease (GERD) Therapeutics Historic Market Size by Type (2015-2020)
• 4.2 Global Gastroesophageal Reflux Disease (GERD) Therapeutics Forecasted Market Size by Type (2021-2026)

5 Gastroesophageal Reflux Disease (GERD) Therapeutics Breakdown Data by Application (2015-2026)

• 5.1 Global Gastroesophageal Reflux Disease (GERD) Therapeutics Historic Market Size by Application (2015-2020)
• 5.2 Global Gastroesophageal Reflux Disease (GERD) Therapeutics Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size (2015-2026)
• 6.2 North America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Type (2015-2020)
• 6.3 North America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Application (2015-2020)
• 6.4 North America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Country (2015-2020)
  • 6.4.1 United States
  • 6.4.2 Canada

7 Europe

• 7.1 Europe Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size (2015-2026)
• 7.2 Europe Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Type (2015-2020)
• 7.3 Europe Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Application (2015-2020)
• 7.4 Europe Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Country (2015-2020)
  • 7.4.1 Germany
  • 7.4.2 France
  • 7.4.3 U.K.
  • 7.4.4 Italy
  • 7.4.5 Russia
  • 7.4.6 Nordic
  • 7.4.7 Rest of Europe

8 China

• 8.1 China Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size (2015-2026)
• 8.2 China Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Type (2015-2020)
• 8.3 China Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Application (2015-2020)
• 8.4 China Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Region (2015-2020)
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 South Korea
  • 8.4.4 Southeast Asia
  • 8.4.5 India
  • 8.4.6 Australia
  • 8.4.7 Rest of Asia-Pacific

9 Japan

• 9.1 Japan Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size (2015-2026)
• 9.2 Japan Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Type (2015-2020)
• 9.3 Japan Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Application (2015-2020)
• 9.4 Japan Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Country (2015-2020)
  • 9.4.1 Mexico
  • 9.4.2 Brazil

10 Southeast Asia

• 10.1 Southeast Asia Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size (2015-2026)
• 10.2 Southeast Asia Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Type (2015-2020)
• 10.3 Southeast Asia Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Application (2015-2020)
• 10.4 Southeast Asia Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Country (2015-2020)
  • 10.4.1 Turkey
  • 10.4.2 Saudi Arabia
  • 10.4.3 UAE
  • 10.4.4 Rest of Middle East & Africa

11 Key Players Profiles

• 11.1 AstraZeneca
  • 11.1.1 AstraZeneca Company Details
  • 11.1.2 AstraZeneca Business Overview
  • 11.1.3 AstraZeneca Gastroesophageal Reflux Disease (GERD) Therapeutics Introduction
  • 11.1.4 AstraZeneca Revenue in Gastroesophageal Reflux Disease (GERD) Therapeutics Business (2015-2020))
  • 11.1.5 AstraZeneca Recent Development
• 11.2 Eisai
  • 11.2.1 Eisai Company Details
  • 11.2.2 Eisai Business Overview
  • 11.2.3 Eisai Gastroesophageal Reflux Disease (GERD) Therapeutics Introduction
  • 11.2.4 Eisai Revenue in Gastroesophageal Reflux Disease (GERD) Therapeutics Business (2015-2020)
  • 11.2.5 Eisai Recent Development
• 11.3 GSK
  • 11.3.1 GSK Company Details
  • 11.3.2 GSK Business Overview
  • 11.3.3 GSK Gastroesophageal Reflux Disease (GERD) Therapeutics Introduction
  • 11.3.4 GSK Revenue in Gastroesophageal Reflux Disease (GERD) Therapeutics Business (2015-2020)
  • 11.3.5 GSK Recent Development
• 11.4 Takeda
  • 11.4.1 Takeda Company Details
  • 11.4.2 Takeda Business Overview
  • 11.4.3 Takeda Gastroesophageal Reflux Disease (GERD) Therapeutics Introduction
  • 11.4.4 Takeda Revenue in Gastroesophageal Reflux Disease (GERD) Therapeutics Business (2015-2020)
  • 11.4.5 Takeda Recent Development
• 11.5 Johnson & Johnson
  • 11.5.1 Johnson & Johnson Company Details
  • 11.5.2 Johnson & Johnson Business Overview
  • 11.5.3 Johnson & Johnson Gastroesophageal Reflux Disease (GERD) Therapeutics Introduction
  • 11.5.4 Johnson & Johnson Revenue in Gastroesophageal Reflux Disease (GERD) Therapeutics Business (2015-2020)
  • 11.5.5 Johnson & Johnson Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Disclaimer

Global Gastroesophageal Reflux Disease (GERD) Therapeutics Scope and Market Size
Gastroesophageal Reflux Disease (GERD) Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Gastroesophageal Reflux Disease (GERD) Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Market segment by Type, the product can be split into
Antacids
Pro-kinetic agents
H2 Receptor Blockers
Proton Pump Inhibitors (PPIs)

Market segment by Application, split into
Heartburn
Acid reflux disorders

Based on regional and country-level analysis, the Gastroesophageal Reflux Disease (GERD) Therapeutics market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa

In the competitive analysis section of the report, leading as well as prominent players of the global Gastroesophageal Reflux Disease (GERD) Therapeutics market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The key players covered in this study
AstraZeneca
Eisai
GSK
Takeda
Johnson & Johnson
...